Back to Journals » OncoTargets and Therapy » Volume 7

Review

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

       
Total article views   HTML views PDF downloads Totals
11,769 Dovepress* 9,374+ 1,546 10,920
PubMed Central* 2,395 452 2,847
Totals 11,769 1,998 13,767
*Since 4 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar